Back
CyberArk Software Vs. Novo Nordisk AS Industry Stock Comparison
Buy
56
CYBR
CyberArk Software
Last Price:
$320.74
Seasonality Move:
10.85%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.33
Seasonality Move:
6.58%
Buy
56
CyberArk Software (CYBR)
is a Buy
Is CyberArk Software a Buy, Sell or Hold?
-
The current CyberArk Software [CYBR] share price is $318.55. The Score for CYBR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
CYBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYBR Stock Price Chart
What is CyberArk Software's stock price today?
-
The CyberArk Software share price today is $318.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYBR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CYBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.64 | Buy |
Relative Strength Index (14 RSI): | 52.91 | Buy |
Chaikin Money Flow: | 241563 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (313.38 - 325.8) | Sell |
Bollinger Bands (100): | (269.01 - 310.99) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.52 | Sell |
Relative Strength Index (14 RSI): | 27.28 | Sell |
Chaikin Money Flow: | 14079249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.16 - 111.42) | Sell |
Bollinger Bands (100): | (106.53 - 131.27) | Sell |
CYBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 316.23 | Buy |
20-day SMA: | 320.16 | Sell |
50-day SMA: | 305.62 | Buy |
200-day SMA: | 271.36 | Buy |
8-day EMA: | 316.98 | Buy |
20-day EMA: | 316.23 | Buy |
50-day EMA: | 306.89 | Buy |
200-day EMA: | 272.29 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.84 | Sell |
20-day SMA: | 105.84 | Sell |
50-day SMA: | 108.65 | Sell |
200-day SMA: | 126.03 | Sell |
8-day EMA: | 99.1 | Sell |
20-day EMA: | 103.93 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.8 | Sell |
CyberArk Software Earnings Growth & CYBR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.17 per share, and an increase next year of $0.66 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
CyberArk Software Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |